Table 1.
General characteristics of the cohort.
| Characteristic | Categories | Value |
|---|---|---|
| PATIENT/TUMOR CHARACTERISTICS | ||
| Age (years) | 55 (IQR 44.0 – 68.8) | |
| Histology | Adeno | 40 (10.0%) |
| Squamous | 342 (85.5%) | |
| Other | 18 (4.5%) | |
| FIGO stage | IB | 46 (11.5%) |
| IIA | 15 (3.8%) | |
| IIB | 174 (43.5%) | |
| IIIA | 18 (4.5%) | |
| IIIB | 102 (25.5%) | |
| IVA | 38 (9.5%) | |
| IVB | 7 (1.8%) | |
| Lymphadenopathy | Negative | 197 (49.3%) |
| Iliac | 139 (34.8%) | |
| PAO | 61 (15.3%) | |
| Missing | 3 (0.8%) | |
| Induction chemotherapy | No | 299 (74.8%) |
| Yes | 101 (25.3%) | |
| RADIATION THERAPY CHARACTERISTICS | ||
| Radiation technique | 3DCRT | 308 (77.0%) |
| IMRT | 50 (12.5%) | |
| VMAT | 42 (10.5%) | |
| Radiation field | Pelvic | 287 (71.8%) |
| Pelvic + PAO | 113 (28.3%) | |
| Brachytherapy use | No | 30 (7.5%) |
| Yes | 369 (92.3%) | |
| Missing | 1 (0.3%) | |
| Image (MRI) guided brachytherapy | No | 334 (83.5%) |
| Yes | 66 (16.5) | |
| HYPERTHERMIA TREATMENT CHARACTERISTICS | ||
| N of treatments | 2 | 10 (2.5%) |
| 3 | 11 (2.8%) | |
| 4 | 50 (12.5%) | |
| 5 | 329 (82.3%) | |
| Cumulative TRISE (degrees Celsius) | 3.46 (2.93-3.86) | |
| Missing | 27 (6.8%) | |
| Cumulative CEM43T90(minutes) | 3.40 (IQR 1.89–5.83) | |
| Missing | 27 (6.8%) | |
| Treatment duration (minutes) | 90.0 (IQR 88.0-90.0) | |
| Missing | 27 (6.8%) | |
| Mean time interval (minutes) | 74.0 (IQR 62.0-94.0) | |
| Missing | 8 (2%) | |